Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl]amide congeners as muscarinic agents

N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl]amide congeners as muscarinic agents

US Patent 5274121 · Granted Dec 28, 1993

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

A1 adenosine receptor agonists and methods of use thereof2025
Compounds and methods for treating neurological and cardiovascular conditions2025
Treatment and prevention of neuropathic pain with P2Y14 antagonists2023
Heterocyclic P2Y14 receptor antagonists2023
Microarray slides that enhance fluorescent signals via plasmonic interaction2021
Methods for pharmacologic treatment of stroke2020
Triazole derivatives as P2Y14 receptor antagonists2020
A3 adenosine receptor agonists2020
Methanocarba derivatives of pseudoribose that inhibit adenosine kinase2018
A3 adenosine receptor agonists2018
Compositions and methods to treat cardiac diseases2016
A3 adenosine receptor allosteric modulators2016